Revenue
2022
2023
2024
2025
Rtw Biotech Opportunities Ltd (RTW)
Price$2.42Cached quote
Net income
2021
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $250.9M | $38.7M | $86.3M | −$36.5M | — |
| Research & development | — | $849,452 | $474,511 | $742,738 | $237,984 |
| Operating expenses | $5.7M | $4.5M | $3.1M | $2.9M | — |
| Net income | $245.2M | $34.2M | $83.2M | −$39.4M | −$64.3M |
| Net profit margin | 97.73% | 88.25% | 96.40% | — | — |
| Basic EPSper basic share | $0.63 | $0.11 | $0.36 | -$0.17 | — |
| Diluted EPSper diluted share | $0.63 | $0.11 | $0.36 | -$0.17 | — |